11-2135814-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000612.6(IGF2):​c.-6-285G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.555 in 152,116 control chromosomes in the GnomAD database, including 24,310 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.55 ( 24310 hom., cov: 34)

Consequence

IGF2
NM_000612.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.336

Publications

26 publications found
Variant links:
Genes affected
IGF2 (HGNC:5466): (insulin like growth factor 2) This gene encodes a member of the insulin family of polypeptide growth factors, which are involved in development and growth. It is an imprinted gene, expressed only from the paternal allele, and epigenetic changes at this locus are associated with Wilms tumour, Beckwith-Wiedemann syndrome, rhabdomyosarcoma, and Silver-Russell syndrome. A read-through INS-IGF2 gene exists, whose 5' region overlaps the INS gene and the 3' region overlaps this gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2010]
INS-IGF2 (HGNC:33527): (INS-IGF2 readthrough) This locus includes two alternatively spliced read-through transcript variants which align to the INS gene in the 5' region and to the IGF2 gene in the 3' region. One transcript is predicted to encode a protein which shares the N-terminus with the INS protein but has a distinct and longer C-terminus, whereas the other transcript is a candidate for nonsense-mediated decay (NMD). The transcripts are imprinted and are paternally expressed in the limb and eye. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.671 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000612.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IGF2
NM_000612.6
MANE Select
c.-6-285G>C
intron
N/ANP_000603.1P01344-1
IGF2
NM_001127598.3
c.163-285G>C
intron
N/ANP_001121070.1P01344-3
IGF2
NM_001007139.6
c.-6-285G>C
intron
N/ANP_001007140.2P01344-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IGF2
ENST00000416167.7
TSL:1 MANE Select
c.-6-285G>C
intron
N/AENSP00000414497.2P01344-1
IGF2
ENST00000434045.6
TSL:1
c.163-285G>C
intron
N/AENSP00000391826.2P01344-3
IGF2
ENST00000381392.5
TSL:1
c.-6-285G>C
intron
N/AENSP00000370799.1P01344-2

Frequencies

GnomAD3 genomes
AF:
0.555
AC:
84371
AN:
151998
Hom.:
24290
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.440
Gnomad AMI
AF:
0.731
Gnomad AMR
AF:
0.681
Gnomad ASJ
AF:
0.566
Gnomad EAS
AF:
0.282
Gnomad SAS
AF:
0.403
Gnomad FIN
AF:
0.603
Gnomad MID
AF:
0.462
Gnomad NFE
AF:
0.618
Gnomad OTH
AF:
0.571
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.555
AC:
84416
AN:
152116
Hom.:
24310
Cov.:
34
AF XY:
0.551
AC XY:
40993
AN XY:
74360
show subpopulations
African (AFR)
AF:
0.440
AC:
18229
AN:
41470
American (AMR)
AF:
0.682
AC:
10433
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.566
AC:
1964
AN:
3468
East Asian (EAS)
AF:
0.281
AC:
1457
AN:
5176
South Asian (SAS)
AF:
0.405
AC:
1956
AN:
4830
European-Finnish (FIN)
AF:
0.603
AC:
6387
AN:
10600
Middle Eastern (MID)
AF:
0.442
AC:
130
AN:
294
European-Non Finnish (NFE)
AF:
0.618
AC:
41985
AN:
67958
Other (OTH)
AF:
0.572
AC:
1210
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1885
3770
5654
7539
9424
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
714
1428
2142
2856
3570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.471
Hom.:
1386
Bravo
AF:
0.561
Asia WGS
AF:
0.362
AC:
1259
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
7.0
DANN
Benign
0.35
PhyloP100
-0.34
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3213221; hg19: chr11-2157044; API